JCR Pharmaceuticals (JCRRF) Stock Price, News & Analysis

Company Overview

JCR Pharmaceuticals Co., Ltd. is a Japan-based biopharmaceutical company focused on developing and commercializing treatments for rare diseases and other conditions with significant unmet medical needs. The company’s research programs include biologics, enzyme replacement therapies, growth hormone products, and regenerative medicine, with an emphasis on applying biotechnology to improve patient care.

JCR’s portfolio includes therapies for rare lysosomal storage disorders and pediatric diseases. Its pabinafusp alfa product, marketed in Japan as IZCARGO, uses the company’s J-Brain Cargo platform, which is designed to help transport therapeutic proteins across the blood-brain barrier. JCR also develops additional investigational treatments based on this technology for neurological and other disorders.

Founded in 1975 and headquartered in Ashiya, Hyogo, Japan, JCR primarily serves the Japanese market while pursuing international development and commercialization opportunities through partnerships and licensing arrangements. The company’s operations combine research and development, manufacturing, and commercialization of specialty pharmaceutical products.

Key Stats

• Today's Range: $3.73 to $3.73
• 50-Day Range: $3.33 to $3.73
• 52-Week Range: $3.15 to $3.73
• Volume: N/A
• Average Volume: 260 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:JCRRF
• CIK: N/A
• Web: www.jcrpharm.co.jp
• Phone: 81 7 9732 8591
• Fax: N/A
• Employees: 934
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A